The Kennel Club Charitable Trust has announced that nominations are now open for its new Veterinary Awards for veterinary surgeons, scientists and veterinary students that are carrying out innovative research that will help to improve dog health.
According to the charity, the Awards will identify and encourage visionary thinking, ambition and life-changing accomplishments and those who receive the awards will be passionate about making a difference for dogs. Each award provides a large funding programme to the recipient, which rewards them for their dedication and innovation in the field of canine health and welfare and invests in helping them to continue making a difference for dogs. The awards will be:
The awards will be judged by representatives from the veterinary profession and the world of scientific research, including experts in the nominees' selected fields. Dr. Alan Kelley, Dean Emeritus of The University of Pennsylvania School of Veterinary Medicine, will chair the distinguished committee selecting the International Prize Winner.
Vernon Hill, Founder and President of Metro Bank and Shirley Hill, whose Foundation underwrites the Awards, said: "Metro Bank is a visionary, innovative bank, and we support the same spirit in these prestigious awards. Dogs Rule at Metro Bank, and we welcome them in with fresh water bowls, treats and Metro Scarves 361 days a year. We look forward to our gift making a difference and supporting the future leaders in veterinary science."
Rosemary Smart, Kennel Club Chief Executive, said: "We are extremely pleased to be working with Vernon and Shirley in this exciting Awards scheme, which will reward and support those people whose work is making a difference to dogs' lives."
To nominate somebody for these awards contact: cas.oakes@thekennelclub.org.uk or write to:
Cas OakesThe Kennel Club Charitable Trust1-5 Clarges StreetPiccadillyLondonW1J 8AB
Nominations for the Student Inspiration should come from the Deans/Faculty Directors of British Veterinary Schools.
For further information and to find out how to enter visit: www.thekennelclub.org.uk/charitabletrust
The Kennel Club Genetics Centre at the AHT has identified a genetic mutation which causes a severe progressive disease in Parson Russell Terriers (PRTs).
Late onset ataxia (LOA) affects coordination and balance, making everyday movement and tasks increasingly difficult. The new DNA test can accurately predict the risk of developing the disease in 97-100 per cent of PRTs and will effectively reduce the number of LOA cases in the breed.
Dogs usually develop the disease between six months and one year of age but because there is no cure, sufferers are usually euthanised around two years after onset as their quality of life diminishes.
After testing DNA of over 200 PRTs in total, the AHT's scientists were able to isolate the genetic mutation which causes the disease and establish that LOA is an inherited recessive trait; therefore dogs must have two defective copies of the genetic mutation, one from each parent, to be affected.
The test results will inform dog owners if their dog is clear from, a carrier of, or affected by LOA.
Cathryn Mellersh, Head of Canine Genetics, at the AHT said: "This is great news for PRT breeders as we believe LOA is an emerging condition in the breed and through this test we should be able to cut the disorder 'off at the pass', before the mutation becomes any more widespread.
"Interestingly, our research also suggests that there may be other causes of ataxia in the breed. It is important for breeders to understand that a clear result using the LOA DNA test will not exclude the formal possibility that dogs could still develop a genetically different form of ataxia."
Caroline Kisko, Kennel Club Secretary, said: "LOA is a relatively new but devastating condition and we are delighted that we've been able to work with the Animal Health Trust to develop a DNA test that will give breeders the opportunity to significantly reduce this disease. We will keep working together to develop tools and information for breeders, so that they are able to select dogs that will have healthy puppies."
The DNA test for LOA is available from the AHT at the price of £48. Full details are available at www.ahtdnatesting.co.uk.
A new company supplying pet chews to the veterinary profession has launched this month.
The Soft Chew Company has been set up by Kevin Ingram, owner of the veterinary supplier J.A.K Marketing and Niall McFerran, who has in the past worked for a number of veterinary healthcare companies including Animalcare, Ceva and Alstoe.
Kevin said: "The healthcare supplement market in the UK is worth over £20 million and rising but most customers are asked to use products which were designed for use on humans. The aim of The Soft Chew Company is to provide those health benefits in the form of treats that the dogs and cats will readily accept."
The new company's product range will be branded: "Chewz" and marketed as palatable healthcare supplements in order that they will not be confused with pharmaceutical products.
The range will initially consist of:
The Chewz range can be obtained from all wholesalers or directly from J.A.K Marketing.
For further information contact; info@thesoftchewcompany.co.uk or 01347 293150
For the project, the company has developed a Brachycephalic Obstructive Airway Syndrome (BOAS) clinical assessment tool which can be used by a vet or nurse in practice to make a diagnosis.
The assessment is a holistic one which includes taking a history of the animal, a full physical examination, an exercise test and an examination of the dog’s nostrils.
The results of the assessment are then discussed with the owner to agree on a course of treatment.
During each consultation, vets and nurses also look to talk sensitively with clients about breeding, buying and owning brachycephalic dog breeds, offering welfare advice on how to manage their dog’s lifestyle, including issues such as keeping their weight low and looking after them in hot weather.
CVS says it hopes this will increase a general level of welfare awareness amongst brachycephalic dog owners.
CVS has also created a collection of resources for its teams, including new clinical frameworks and veterinary guidelines, webinars and a CPD day on the subject.
The company has also created materials to help vets and nurses have what can be challenging discussions with clients, including consultation room posters and practice reception TV videos which showing the physiology of the brachycephalic breed.
CVS says that since launch in July last year, the 25 participating practices have conducted nearly 900 brachycephalic assessments, and it aims to have at least 5% of Pugs, French Bulldogs and Bulldogs undergoing assessment across its small animal division by 2028.
Veterinary surgeons and veterinary nurses will be able to try their hands at the Royal College of Veterinary Surgeons code-cracking competition at the London Vet Show at Olympia on 24-25 November.
At the RCVS breakfast session on the Friday morning (8.30, part of the Business Stream), President Dr Jerry Davies will unlock the secrets of the proposed new Codes of Professional Conduct for vets and VNs.
To promote this breakfast session, the RCVS is inviting visitors to come to its stand (J90) to solve photo enigmas, using clues provided to decipher a series of words that appear in the proposed new Codes. The winner will be in line to receive a pair of super sleuthing video glasses.
VNs who missed BVNA Congress can also get their hands on a 50th anniversary commemorative chocolate medallion by visiting the RCVS stand.
Coffee and pastries will be served at the morning session on Friday - there's no need to book, just turn up.
Vetoquinol has announced that the 50g pack size of Ipakitine will shortly be replaced by a 60g pot.
The company says this will provide the convenience of a 30 day supply for a 5kg cat or dog who is on 1g/5kg bodyweight twice a day (one level scoop twice a day).
The 60g pot will be available from the end of December. Also at this time, the existing 150g size pot will be replaced by a 180g pot.
The new packaging is more eye-catching, easier to read and gives more description. A 300g pot will also be available in February 2012. Pricing will be in-line with increase in pack size, so proportionally a 20% increase for 20% more product.
Ipakitine is a phosphate binder formulated specifically for veterinary use. It is designed for both cats and dogs and is available as a tasteless powder formulation for easy administration with food.
Researchers at the Royal Veterinary College (RVC) have developed a system that eliminates the need for antibiotics and resistance genes in the engineering of industrial and medical products.
The method involves safer, less costly alternatives and is well suited for industrial production of many biofuels and biopharmaceuticals. This research has been published in the online access journal BMC Biotechnology.
Genetic engineering underpins much of biotechnology, and antibiotic selection of engineered strains is a key tool. Unfortunately, antibiotic selection methods risk spreading resistance traits, particularly as biotechnology products move into the environment and clinic. There have been alternatives, but none are satisfactory for wide application.
Gene targeting is the insertion of DNA into specific sites or genes within the genome of selected cells in order to alter gene expression for a particular purpose.
While working on gene targeting in bacteria, RVC researchers discovered that a well-known interaction between a cell membrane synthesis gene and the biocide triclosan could be exploited for strain selection. Surprisingly, triclosan selection performs better than conventional antibiotic selection.
"We think this simple technology is well suited for industrial scale fermentations that produce a range of valuable products, including bio-fuels and bio-pharmaceuticals," said Dr Liam Good, at the Royal Veterinary College and lead researcher on the project. "More importantly, the new system is relatively safe and inexpensive, because the gene is native in all bacteria and triclosan is approved for use in many household applications."
The research was carried out with Dr Shan Goh of the Department of Cell and Molecular Biology, Karolinska Institute, Stockholm.
Janssen Animal Health is encouraging vets and nurses to think 'chicken' this spring.
According to the company, all the evidence suggests that there has been a massive increase in the number of people keeping a few chickens in their garden, resulting in a new breed of chicken owner who often has different expectations regarding healthcare, and views their birds as 'pets'.
Vet Nigel Underwood from Janssen Animal Health said: "It is very tempting for small animal practitioners to think that domestic poultry keepers are the preserve of large animal practices but it is very likely that many cat and dog owners will own chickens too and trust their vet to give them advice about the basic healthcare needs of all their pets."
This spring there is a big opportunity to make poultry owners aware of the need to worm their birds. The return of warmer weather can signal an increase in poultry worm numbers as the ambient temperature increases above 10 degrees centigrade and more worm eggs become infectious. Studies have shown that peak worm counts often coincide with peak chicken egg production. Unless chickens, turkeys and geese are de-wormed there is a risk that egg production could suffer, just when poultry keepers should be enjoying their best yields. Some may even notice smaller eggs and loss of shell and yolk colour. Birds may suffer weight loss, become anaemic or even die.
One study has shown that older birds are more likely to harbour worms and many domestic poultry keepers find themselves with an ageing flock because they allow their birds to live a full natural lifespan. Free range birds are also much more at risk of picking up parasitic worms because of increased exposure to the outdoors, more contact with wild birds and the opportunities to ingest intermediate hosts such as earthworms, beetles and snails.
Janssen Animal Health's Flubenvet® 60 gram pack is an in-feed treatment that, according to the company, is practical even for those with just a few hens in their garden. Flubenvet 60 gram contains enough wormer to treat around 20 chickens, with no egg withdrawal.
While worms are a year-round problem in poultry it is especially important to treat in the spring to tackle the increasing threat of worm infection. Thereafter, poultry owners will also get the best results if they continue to treat regularly in spring, summer and autumn, when new birds are acquired and before putting birds out to pasture. This helps to ensure that contamination of the chickens' environment with worm eggs is kept at a manageable level, reducing the risk of future infections.
Free client leaflets about worms affecting chickens, geese and turkeys are available by calling Janssen Animal Health on 01494 567555.
CEVA Animal Health has announced that all dogs entering Dogs Trust's 17 Rehoming Centres will now be fitted with a D.A.P.® collar to help reduce their stress levels while in a kennel environment. This decision was taken following a highly successful trial1 at Dogs Trust's state-of-the-art Rehoming Centre in West London.
The trial revealed that dogs wearing D.A.P.® collars while in kennels were less likely to display canine stress indicators, such as barking and pacing around kennels, and were more likely to lie down and rest; signs that dogs are more relaxed.
Chris Laurence, veterinary director at Dogs Trust, said: "Dogs Trust trialled D.A.P.® collars on dogs being admitted at our Harefield Rehoming Centre. Many dogs are very stressed by their first experience in a kennel environment and it was shown that the use of a collar significantly reduced their stress levels.
"Centre staff were impressed with the positive changes in behaviour that were shown during the trial. Dogs were far more relaxed and less reactive to the inevitable stressful elements of their environment. We will now be using D.A.P.® collars on all dogs entering our Rehoming Centres in tandem with the other practices we already employ to reduce kennel stress.
"Stressed dogs are more difficult to rehome so we hope the use of DAP® to reduce stress levels will be beneficial to both their welfare and our rehoming."
For further information on D.A.P.®, please contact your local CEVA Animal Health territory manager, or visit www.ceva.uk.com.
Alternative remedies which could be dangerous to pets are being targeted by the Government in a major drive to improve animal health and welfare. Some herbal and homeopathic products are claiming medicinal benefits without scientific proof, meaning they may not properly treat or prevent serious diseases, leaving pets at risk.
The Veterinary Medicines Directorate’s (VMD) Director of Operations, John FitzGerald, said: "Some of these products are claiming to be effective and safe when no scientific evidence has been presented to us to show they are.
"Animal owners have a right to know if a product does what it claims. The products claim to treat diseases which can cause serious welfare problems and in some circumstances kill animals if not properly treated. So in some cases owners are giving remedies to their pets which don’t treat the problem."
A number of unauthorised products are being targeted, including:
From now on, the VMD will be contacting manufacturers to ensure that they demonstrate the products are safe and provide the benefits which they claim to. If this is not the case the manufacturers will be required to re-brand the products to make it clear they are not medicinal.
Supporting the action, British Veterinary Association President Harvey Locke said: "As veterinary surgeons we rely on the use of safe, effective and quality medicines for the health and welfare of animals under our care – and there must always be sound scientific evidence to back up medicinal claims made by the manufacturer of any product.
"Some of these unauthorised products may at the least be ineffective and at worst could cause harm because serious life-threatening diseases may go undiagnosed. We would urge animal owners always to check with their veterinary surgeon before giving any remedy or supplement to their pet."
Burgess Excel and the PDSA are urging veterinary surgeons and nurses to get their clients to sign up to the free PDSA Rabbit Wellbeing Challenge by the closing date of Friday 22 November.
According to the organisers, the PDSA Rabbit Wellbeing Challenge is designed to help all rabbit owners understand and meet their pets' five welfare needs - the five things that all pet rabbits' need to be healthy and happy. Since the campaign was launched in June, more than 1,000 rabbit owners have signed up to take the challenge, and veterinary practices are now being urged to ensure their clients take advantage of this free resource by visiting www.rabbitneeds.org.uk to register.
The Challenge website allows owners to take a monthly quiz to find out how well they are currently meeting their rabbits' needs, with advice on how to further improve their health and wellbeing. At the end of the challenge, owners will be presented with a Rabbit Wellbeing Challenge certificate and receive monthly vouchers together with money-off coupons for the Excel Feeding Plan. They will also be entered into a prize draw to win a 16gb iPad.
The Challenge is being featured on stickers on every pack of Burgess Excel Rabbit Nuggets. One million packs will have been sold by the final date for sign ups on the 22 November.
Burgess Pet Care Veterinary Surgeon, Suzanne Moyes, said: "With help from the veterinary community we really can make a difference by raising awareness about important rabbit welfare issues and in turn change rabbit owner behaviour. Working together, we are can improve the health and wellbeing of the UK's third most popular pet by educating pet owners, especially in relation to diet and regular veterinary check-ups."
Sean Wensley, Senior Veterinary Surgeon at PDSA, added: "Sadly, the welfare needs of pet rabbits are often not met. Common problems include a poor diet, living alone in a small hutch with no exercise run, and a lack of preventive healthcare. The PDSA Rabbit Wellbeing Challenge is a great tool for owners to assess how well they are currently meeting their rabbit's five welfare needs and to get advice on making practical, positive improvements. Most owners want their pets to be healthy and happy, and we hope this Challenge will help tackle some of the preventable health and welfare problems commonly seen in pet rabbits."
For further information on The PDSA Rabbit Wellbeing Challenge visit www.rabbitneeds.org.uk or for further details on the Burgess Excel Feeding Plan visit www.excelfedingplan.co.uk
Canterbury-based solicitor Cooper & Co, which specialises in dog law, has launched a series of CPD-qualifying webinars for veterinary professionals available at www.doglaw.tv.
The webinars, which are presented by Trevor Cooper, cover a wide variety of subjects, including:
In addition, the site hosts videos about dog behaviour by the well-known dog trainer and behaviourist Carolyn Menteith. The topics covered in her videos include:
Whilst the videos are CPD-qualifying for veterinary professionals, they are also aimed at anyone else that works with dogs, and dog owners themselves.
To view the videos visit www.doglaw.tv.
The review coincided with a move last month from RUMA, the agricultural and food industry alliance which promotes responsible use of medicines in farm animals, to align with the EMA position.
The announcement means that under PVS guidelines, fluoroquinolones, 3rd and 4th generation cephalosporins and colistin will retain Class 3 status. This means they are only used when no other options are available and when supported by laboratory sensitivity testing – or exceptionally when all other options have failed.
Class 1 antibiotics form the standard prescribing list within responsible use guidelines and Class 2 are used only when sensitivity tests or clinical experience proves standard antibiotics are not effective. In all treatment decisions the health and welfare of the pigs must always take priority.
Betalactams with betalactamase inhibitors (clavulanic acid) were previously in the highest priority Class 3 but in light of the list defined by the EMA, which has been adopted by the Veterinary Medicines Directorate as well as RUMA, the PVS has reassessed the risk and moved them to Class 2 to align them with plain betalactams. This means they are still subject to voluntary restrictions, but their use would not necessarily be only as a last resort.
PVS president Mark White said that despite the ongoing review process and the potential to reclassify certain products, the Society’s underlying principles remain unchanged: "The total amount of all antibiotics used on pig farms to treat and prevent disease should be minimised, and the types of antibiotics used in pigs should be considered in light of the implications for antibiotic resistance challenges in both pigs and man.
"This policy is proving successful with AHDB Pork’s electronic pig medicine book (e-MB) recently showing that use of colistin appears to have fallen by over 70% in 2016 following its move to a Class 3 antibiotic in late 2015.
"We must also continue to be alert to the possibility of cross resistance, even in older antibiotics that have little or no use in humans. Risk must be acknowledged where it exists and overall reductions are still imperative."
RUMA has welcomed the review and alignment from the PVS. Secretary General John FitzGerald said: "Farmers and vets need boundaries within which to operate and clear objectives to meet, and we would urge all supply chains, from farmer to retailer, to align with the sector position on best practice use of antibiotics, as defined by each sector’s professional veterinary organisation."
Biogal has announced the launch of the PCRun Molecular Detection Kit, designed to give PCR results in clinic or in the lab within an hour.
The new kit doesn't require any other equipment, such as a thermocycler.
PCRun is a molecular assay based on the isothermal amplification of part of the HapI gene. The company says it is intended for the qualitative detection of pathogenic species of Leptospires only.
The PCRun has been tested at the OEI Leptospira Reference Laboratory in Ireland, on sample materials including urine and kidney biopsies collected from cows experimentally infected with L. hardjo as well as kidney cells.
According to the company, no false positive results were observed in all 63 samples tested and there was excellent correlation between Real Time PCR and PCRun reactions.
Results of the study and a list of serovars tested with PCRun are available from Biogal. See: http://www.biogal.co.il/products/pcrun
CPC, the pet crematorium, has developed a new online survey tool to help practice staff analyse the effectiveness of their bereavement care capabilities.
Called "Bereavement Care - How does your practice compare?", the online survey comprises a series of multiple choice questions designed to produce a star rating out of 5. The idea is that these questions will help practices establish whether they need to improve how staff deal with bereaved pet owners.
Duncan Francis, Director, CPC said: "Coping with the loss of a much-loved pet is never easy for a bereaved owner. While support from those who are close to both the owner and the pet can make a real difference, many vets and vet nurses have received little training on this sensitive topic.
"Understanding client's needs before, during and after euthanasia, helps staff establish a rapport with emotional clients at a critical time and maintains a positive practice image.
"The aim of the survey is to raise awareness among vets and vet nurses of the importance of feeling confident in their ability to help bereaved owners through their grief. This helps clients come to terms with the death of their pet enabling them to move on and welcome another companion animal into their lives."
To find out more about how CPC can help your practice to improve its bereavement care, please ring 01763 207700, email info@cpccares.com or visit www.cpcvets.com
The BSAVA has announced Richard Dawkins as its headline speaker at BSAVA Congress 2013 next April.
Richard follows in the footsteps of Lord Robert Winston and Susan Greenfield as the special speaker for the BSAVA lecture.
The talk, sponsored by Anistel, takes place on the Thursday afternoon of in Hall 1 and is open to all Congress delegates.
Dawkins is a prolific writer who first came to prominence with his 1976 book The Selfish Gene, his strident manifesto for secularism. However it is The God Delusion that now finds him so frequently called upon for comment. Along with Stephen Hawkins, he is one of the few scientists that members of the public can easily identify, in part due to his willingness to engage in academic and media debates.
Dawkins was born in Nairobi in 1941 where his father worked for British colonial service. He returned to Britain after the war to grow up on the family's estate farm. He studied zoology at Balliol College, Oxford, where he was tutored by Nobel Prize-winning ethologist Nikolaas Tinbergen, graduating in 1962. He received his M.A. and D.Phil. degrees by 1966, and remained a research assistant for another year, when his research concerned models of animal decision-making.
He has since been an assistant professor of zoology at the University of California, Berkeley, and a lecturer and reader in zoology at University of Oxford. In 1995 he was appointed Simonyi Professor for the Public Understanding of Science, a position that had been endowed by Charles Simonyi with the express intention that the holder "be expected to make important contributions to the public understanding of some scientific field", and that its first holder should be Richard Dawkins.
Image courtesy Zoe Margolis
Petlog has released the results of research to discover what dog owners know about microchipping and the upcoming change in legislation which will make chipping compulsory from 2016.
The survey was conducted amongst 1000 people in May. 46% of those that own dogs were unaware that microchipping is to become compulsory. Of the 54% that did know about the new legislation, only about 20% knew that it comes into force in 2016.
The survey revealed a surprising lack of understanding about how microchips work. 14.85% of dog owners - which would amount to more than 1M people in the UK - thought a microchip acted as a GPS device.
Half of all pet owners did not know whether the contact details on their pet's microchip record are up to date.
Petlog conducted the survey as part of National Microchipping Month which takes place this June. The awareness campaign has been running for 10 years now, to raise the profile of pet microchipping and its benefits and also to educate pet owners about how it works, the need to keep contact details up to date and how to make the most from a database.
Celia Walsom, Petlog Executive said: "Raising awareness about microchipping was our first priority when we began National Microchipping Month in 2004, but now we want to ensure pet owners fully understand exactly how the microchip works, that they need to keep their contact details up to date and of course are aware of what is happening in regards to legislation.
"Microchipping is the most popular form of permanent identification, and has reunited hundreds of thousands of pets and owners in the UK since it was introduced here over twenty years ago, and yet pet owners do not seem to fully understand how the microchip works and why it is so important to keep their contact details up to date.
"Worryingly the research found that around 12% of pet owners wrongly believe that the microchip acts as some sort of GPS device, or can stop a pet from wandering a certain distance. It is important that people understand how a microchip works so that they know how to make the most of it.
"We also need pet owners to understand that they need to keep their contact details up to date as it becomes a lot harder and slower, if possible at all, to reunite pets when contact details become outdated."
Talking about Petlog's annual campaign, Animal Welfare Minister, Lord de Mauley said: "I fully support National Microchipping Month. Campaigns like this are important in showing dog owners that microchipping is a safe, easy and quick procedure that can save owners a lot of potential heartbreak if their dogs stray. With Dogs Trust, Battersea Dogs and Cats Home, and Blue Cross all offering free microchipping, there is no excuse for dog owners not to chip their dogs before the April 2016 deadline."
To find out more about National Microchipping Month and events that are taking place in your area, visit www.nationalmicrochippingmonth.org.uk.
CarefreeCredit, the vet-run company we reported on back in October, has announced that it is working with its 600th practice in offering its interest-free or low-interest credit to clients that find themselves unable to pay for unforeseen veterinary treatment.
Stewart Halperin MRCVS, Managing Director of CarefreeCredit said: “2014 has been an incredibly busy but successful year for us. We’ve increased the take up of our service by over 500%, we have proudly cemented our partnerships within the corporate and buying groups and most importantly, we have become established enough to make a substantial difference to the pets and pet owners who rely on the help our service provides.”
Stewart added: “We know 2015 is going to be an even bigger year for us, with even more practices joining our system and the introduction of dependable and innovative business support services that will continue to save our practices time and money and help them increase sales and reduce debtors. With this in mind, we are introducing a very small monthly charge to cover our increased costs in software, training and office support services.”
From the New Year, practices that join Carefree Credit will be charged a flat rate of £10 per month for the duration of their membership. The £10 monthly fee covers support for FCA applications, unlimited training in-practice or online, use of the CarefreeCredit unique platform, CarefreeCredit office support, and point of sale materials. Practices that sign up before January 1st, will continue their membership without charge until at least January 2016.
For further information, visit: carefreecredit.co.uk or ring 0203 697 8439.
The meeting will be led by Dr Rosanne Jepson BVSc MVetMed PhD DipACVIM DipECVIM PGCertVetEd FHEA MRCVS, Associate Professor Small Animal Internal Medicine Specialist at the RVC. It will consist of two talks.
The first, ‘Hypertension and concurrent diseases’, will cover how veterinary surgeons should manage and treat hypertension when it presents with other concurrent diseases such as CKD and hyperthyroidism.
The second, ‘Overview of diagnosis and stage specific management of feline CKD’, will review the recently updated IRIS guidelines and discuss the latest and most up-to-date methods in diagnosing and managing CKD in both the early and later stages.
The meeting will account for two hours CPD.
To register for the CPD meeting, contact your local Ceva account manager or email your name, practice name and telephone number to cevauk@ceva.com.
The College says the consultation, which closes on 22nd December, reflects its commitment to keep reviewing its requirements for newly-qualified VNs to ensure they remain up-to-date and reflect the standards and expectations of current veterinary nursing practice.
Participants will be asked to comment on a proposed new set of requirements, which is divided into three parts:
Day One Competences: the minimum essential competences that the RCVS expects all student veterinary nurses to have met when they register, to ensure that they are safe to practise on day one.
Day One Skills Lists: the essential clinical skills that veterinary nurses are expected to possess on entering clinical practice.
Professional behaviours and attributes: this encompasses the behaviours newly-qualified veterinary nurses are expected to demonstrate on entering the profession.
Julie Dugmore, RCVS Director of Veterinary Nursing (pictured right), said: “With this consultation we want to gain an effective representation of what the professions desire from future RVNs in term of their range of skills and knowledge and professional behaviours from their first day in clinical practice.
"Any feedback we receive on the proposed new requirements will be vital in helping to ensure that student vet nurses receive the appropriate education and training, and that our RVNs are fully prepared and armed with what is necessary to thrive in and add value to current veterinary clinical practice.
Once the consultation is complete, the responses will be reported to the working group, which will then have a final opportunity to amend and agree the proposals, before being submitted to VN Council for consideration.
The aim is that VN Council will agree to the new version of the requirements in its February 2022 meeting.
The deadline for completing the consultation is 5pm on Wednesday 22 December 2021. A PDF document with the proposed new requirements as well as the link to the online survey can be accessed from www.rcvs.org.uk/VNdayone.
To take part, visit: www.rcvs.org.uk/VNdayone
VRCC the Essex-based veterinary referral specialists and centre for the treatment of cancer in dogs and cats has become the first in the UK to offer a canine melanoma vaccine.
The vaccine, previously only available in the U.S. where it has been granted a conditional license by the USDA, has been made available to VRCC's Head of Oncology Dr Susan North who fulfils the US Academic Credentials required.
According to VRCC, most oral tumours are not noticed early by owners, so many go undiagnosed and untreated until they are advanced and the dog has a poor chance of recovery.
Canine melanoma is an aggressive neoplasm treated with surgery and/or radiation therapy, which readily metastasises to the lymph nodes, liver, lungs and kidneys but is chemo-resistant. There is little evidence that chemotherapy improves survival time.
The canine melanoma vaccine develops effective immunotherapy in dogs that recognises and targets specific antigens on melanoma cells and may account for long-term tumour control and survival.
The vaccine is indicated for dogs with stage II or stage III oral melanoma for which local disease control has been achieved: negative local lymph nodes or positive lymph nodes that were surgically removed or irradiated.
The conditional license was granted based on the reasonable expectation that when used along with surgery and/or radiation therapy to treat the initial tumour the vaccine may help extend survival time and improve quality of life in dogs with canine oral melanoma.
US research concluded that canine patients with advanced disease have a median survival time of less than 5 months with standard therapies. In initial trials, dogs receiving the vaccination sequence had a median survival time of 389 days.
A canine transdermal device is especially matched to the vaccine for needle-free delivery and optimal distribution. Veterinary surgeons with a patient with oral melanoma should contact Dr Susan North at VRCC, www.vrcc.co.uk to discuss the case at an early stage, as initial treatment is important to ensure suitability for the vaccine.
Forum Animal Health is launching a new programme designed for transition cows to help avoid milk fever relapses: the Milk Fever Pack.
According to the company, the new Milk Fever Pack provides a continuous and complete supply of readily available oral calcium to avoid relapses which also gives the cow extra support until her system is back in control. Unlike intravenous calcium, oral calcium will not suppress parathyroid hormone (PTH) release and therefore will not turn off the cow's natural mechanism to regulate blood calcium levels.
Each pack contains one sachet of Agger's® Fresh Cow which supplies essential calcium, energy and rehydrates the cow; and two tubes of Botonic® Calcium which create a mild metabolic acidosis to enable the cow to mobilise calcium efficiently.
Forum Animal Health says the new Milk Fever Pack has been developed in close collaboration with a leading veterinary nutritionist to allow veterinary surgeons to be involved at an earlier stage. The veterinary surgeon can then leave a follow-up protocol for the client to use, helping to avoid milk fever relapses. It gives veterinary surgeons a chance to introduce standard operating procedures into herd health plans bringing better control of milk fever on farms.
For more information, please contact Forum Animal Health on 01737 781416 or animal.health@forumgroup.co.uk.
Dechra Veterinary Products has launched a case study competition to find out how veterinary professionals are using Celox, its new haemostatic agent designed to stop heavy bleeding.
According to the company, Celox Veterinary forms a gel-like clot within 30 seconds when mixed with blood.
Dechra says it would like examples of how it has been used, whether for planned procedures or in an emergency, and is asking veterinary surgeons and nurses to send in case histories and photos for the chance to win an iPad2.
Rachel Horton, Dechra's Brand Manager for Woundcare, said: "Celox Veterinary was launched to the market last year, with the human version of the product being used with great success on the battlefield by the British military for several years.
"Now we are asking veterinary professionals to share their experiences of using Celox Veterinary in practice, whether used in its gauze or granular form. It is ideal for fast-acting haemostasis, and provides a quick and efficient solution wherever and whenever bleeding needs to be stopped fast.
"Entrants providing case histories with accompanying photos can enter as many times as they like and have a chance to win an iPad2. Learning about how veterinary professionals are using products is important to Dechra Veterinary Products and assists in developing the high level of support we offer to vets and vet nurses."
Dechra says Celox Veterinary is being used not only for trauma injuries and emergency first aid but also for planned operations including castration, mass removal, nasal polyps, dental extractions and soft palate resections.
Case histories should be emailed to Rachel.Horton@dechra.com before the closing date of July 20th 2012 to be eligible for the draw. For further information about Celox Veterinary, please visit see www.dechra.com
Vets, consultants and other advisors should encourage dairy farmers to make use of available information to help improve their herd's performance and profitability through breeding. This is the message from DairyCo breeding+ director, Marco Winters, who says farmers should use genetics to improve not only milk production, but also health, welfare, management and type traits.
Breeding briefs, a new booklet from DairyCo, identifies some genetic improvement tools that allow farmers to make better breeding decisions and concentrates on how to use them in practice. And for those who feel confronted by an overload of information, the booklet helps identify the figures to seek out and prioritise.
Breeding decisions are cumulative: their effects build up over the generations so a problem can be introduced or cured over just a few years. A series of poor breeding decisions can mean the difference between profit and loss; even between a business's survival and failure. Yet the time, cost and effort needed for a good breeding decision to be made is much the same as those needed for a bad one.
Mr Winters says: "High quality cattle are at the heart of profitable dairy farming and this requires good quality genetics. Without these, however good farmers' management, there is a ceiling to their herd's performance and profitability. Vets, consultants and other dairy advisers have an important role to play in helping farmers access the information they need to make informed decisions."
DairyCo Breeding briefs is available to download from http://www.dairyco.org.uk/. To request a pdf version by email call 01285 646510 or email: publications@dairyco.org.uk.